| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/16/2005 | EP0970211B1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 11/16/2005 | EP0939799B1 Enzymatic cofactor cycling using soluble pyridine nucleotide transhydrogenase |
| 11/16/2005 | EP0909322B1 Antiviral ricin-like proteins |
| 11/16/2005 | EP0873406B1 Protein induced by deprenyl |
| 11/16/2005 | EP0871746B1 Carboxypeptidases from aspergillus oryzae and nucleic acids encoding same |
| 11/16/2005 | EP0871703B1 Dna encoding glutamate gated chloride channels |
| 11/16/2005 | EP0851868B1 High level expression of green fluorescent protein |
| 11/16/2005 | EP0832232B1 Kunitz type plasma kallikrein inhibitors |
| 11/16/2005 | EP0818532B1 Plant promoter and gene expression with the use of the same |
| 11/16/2005 | EP0788547B1 Purified coprinus laccases and nucleic acids encoding same |
| 11/16/2005 | EP0749491B1 Enhanced expression in a plant plastid |
| 11/16/2005 | EP0741793B1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof |
| 11/16/2005 | EP0741745B1 Hepatitis b vaccine |
| 11/16/2005 | EP0680516B1 High resolution dna sequencing method using low viscosity medium |
| 11/16/2005 | EP0651811B1 K. lactis rp28 ribosomal protein gene promoter and use thereof |
| 11/16/2005 | EP0556207B2 Modified human tnfalpha (tumor necrosis factor alpha) receptor |
| 11/16/2005 | EP0477295B2 Platelet aggregation inhibitors |
| 11/16/2005 | CN2740616Y Biological molecular recovering groove and recovering device |
| 11/16/2005 | CN1697884A Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
| 11/16/2005 | CN1697883A Method of detecting target nucleotide sequence, detection target structure to be used in embodying the method, process for producing the same and assay kit for detecting target nucleotide sequence |
| 11/16/2005 | CN1697882A Multiplex PCR |
| 11/16/2005 | CN1697879A Biomolecule transfer method using virus envelope and composition and system therefor |
| 11/16/2005 | CN1697878A Novel peptides having cAMP producing activity |
| 11/16/2005 | CN1696700A Anti-tag antibody chip for protein interaction analysis |
| 11/16/2005 | CN1696301A Process for clavulanic acid production by microbial thallus |
| 11/16/2005 | CN1696294A High-performance bioreactor for baculovirus of insects |
| 11/16/2005 | CN1696293A Gene recombined chemotaxis antigen vaccine |
| 11/16/2005 | CN1696292A Method for preparing immortalized cell of protein for expressing gene code of infective buresa of Fabricius virus |
| 11/16/2005 | CN1696291A New type mutant of heatlabile enterotoxin from bacteria coli, and preparation method |
| 11/16/2005 | CN1696290A Transport protein and coded gene for producing penicillium chrysogenum, and application |
| 11/16/2005 | CN1696289A Protein of tuberculosis in use for diagnosing tuberculosis |
| 11/16/2005 | CN1696288A Nodulin-like gene of cotton and promotor thereof |
| 11/16/2005 | CN1227533C Reagent for diagnosing cardiac infarction |
| 11/16/2005 | CN1227367C Diagnostic system and method for determining presence of genotoxic compound in sample |
| 11/16/2005 | CN1227363C Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same |
| 11/16/2005 | CN1227362C Biosynthetic genes for spinosyn insecticide production |
| 11/16/2005 | CN1227361C Method of expressing thymus peptide alpha by yeast and use thereof |
| 11/16/2005 | CN1227360C Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them |
| 11/16/2005 | CN1227359C Down-regualtion resistant C3 convertase |
| 11/16/2005 | CN1227358C Identification method of PCR-restriction map for fritillary bulb and similar medicine material |
| 11/16/2005 | CN1227357C Method for amplifying nucleic acid sequence |
| 11/16/2005 | CN1227355C Acetate proof mutant escherichia coli DH5 alpha and its culturing method and use |
| 11/16/2005 | CN1227265C Antibodies to CCR5 |
| 11/16/2005 | CN1227264C Immunogenic peptides derived from MAGE and use thereof |
| 11/16/2005 | CN1227262C Protein related to plant cell cycle and its coding gene |
| 11/16/2005 | CN1227035C Conjugates and method for production thereof, and their use for transporting molecules via biological membranes |
| 11/16/2005 | CN1227030C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 11/16/2005 | CN1227026C Method for using silkworm to express human interleukin 11 to produce medicine |
| 11/16/2005 | CN1226936C Carbohydrate-based enzyme granulates |
| 11/15/2005 | US6965850 Methods for modulating nuclear receptor coactivator binding |
| 11/15/2005 | US6965060 Production of silk-like proteins in plants |
| 11/15/2005 | US6965059 Method of protecting plants by introducing a gene coded for a protein which enhances virus infection of host insects |
| 11/15/2005 | US6965025 Antisense modulation of connective tissue growth factor expression |
| 11/15/2005 | US6965024 Reactive with ganglioside GD3; cancer treatment |
| 11/15/2005 | US6965022 Methods to identify swine genetically resistant to F18 E. coli associated diseases |
| 11/15/2005 | US6965018 Antibodies directed to B7-related polypeptide, BSL-2 |
| 11/15/2005 | US6965017 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 11/15/2005 | US6965010 Polypeptideeptide for use in the treatment of cancer, neovascularization defects, retinopathies, arthritis and psoraisis |
| 11/15/2005 | US6964957 For use in therapy of neurodegenerative diseases and certain cancers |
| 11/15/2005 | US6964951 Polynucleotide |
| 11/15/2005 | US6964950 Oligonucleotides which hybridize with nucleic acids which encode said protein; gene therapy; genetic engineering; for treatment of angina and myocardial infarction |
| 11/15/2005 | US6964944 Chemically modified lipolytic enzyme |
| 11/15/2005 | US6964870 Enhanced selection of genetically modified pine embryogenic tissue |
| 11/15/2005 | US6964868 Human polynucleotides; genetic engineering |
| 11/15/2005 | US6964866 Methods and compositions for highly efficient transformation of filamentous fungi |
| 11/15/2005 | US6964865 Host cells comprising Streptomyces clavuligerus chromosomal DNA fragments encoding enzymes for β-lactam antibiotic biosynthesis |
| 11/15/2005 | US6964863 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
| 11/15/2005 | US6964862 Sample processing device and method |
| 11/15/2005 | US6964861 Enhanced in vitro recombinational cloning of using ribosomal proteins |
| 11/15/2005 | US6964859 Suppressor tRNA system |
| 11/15/2005 | US6964853 Smad6 and uses thereof |
| 11/15/2005 | US6964847 Derivative nucleic acids and uses thereof |
| 11/15/2005 | US6964846 Diagnosis of colorectal cancer; amplification of nucleic acid |
| 11/15/2005 | US6964845 Thermostable phage lambda operator mutants for regulating gene expression |
| 11/15/2005 | US6964770 Recombinant plasmid and a method of controlling the effects of Yersinia pestis |
| 11/15/2005 | US6964769 Molecular antigen array |
| 11/15/2005 | US6964767 Polypeptides; detecting infections using antibodies |
| 11/15/2005 | US6964762 Composition and method for stimulating immune response to pathogen using complex adenoviral vector |
| 11/15/2005 | US6964760 Lantibiotics for treatment and prevention of bacterial infections; useful in antimicrobial or antiseptic dentifrice |
| 11/15/2005 | CA2198723C Plant transcription regulators from circovirus |
| 11/15/2005 | CA2182315C Expression of heterologous proteins in attenuated bacteria using the htra-promoters |
| 11/15/2005 | CA2162481C Marker gene |
| 11/14/2005 | CA2810292A1 Ligand for g-protein coupled receptor fprl2 and uses thereof |
| 11/13/2005 | CA2507567A1 Use of compositions comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions |
| 11/10/2005 | WO2005106473A1 Method of screening therapeutic agent for neurodegenerative disease |
| 11/10/2005 | WO2005106046A1 Modified viral vector particles |
| 11/10/2005 | WO2005106042A2 Improved modulators of coagulation factors |
| 11/10/2005 | WO2005106039A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 11/10/2005 | WO2005106037A1 A method for identifying activators of gene transcription |
| 11/10/2005 | WO2005106031A1 Method of hybridization |
| 11/10/2005 | WO2005106030A1 Method of nucleic acid detection |
| 11/10/2005 | WO2005106029A1 Method of analyzing nucleic acid |
| 11/10/2005 | WO2005106028A1 Method of identifying target of compound acting on natural immunity |
| 11/10/2005 | WO2005106024A1 Method and assembly for dna isolation with dry reagents |
| 11/10/2005 | WO2005106023A1 Pcr process and arrangement for dna amplification using dry reagents |
| 11/10/2005 | WO2005106015A1 Method of screening remedy for diabetes |
| 11/10/2005 | WO2005106011A2 Process for preparing dipeptidyl iv inhibitors and intermediates therefor |
| 11/10/2005 | WO2005106010A2 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins |
| 11/10/2005 | WO2005106005A1 Process for producing hydroxycarboxylic acid |
| 11/10/2005 | WO2005106002A2 Polyvalent viral vectors and a system for production thereof |